ADA Scientific Sessions 2026 Abstract

Indication-Specific Adverse Event Profiles of Semaglutide and Liraglutide: A FAERS Disproportionality Analysis

By Silvia Fisch, Eitan J. Neugut, Nicole Cornet, Daniel Freedberg

Study in peopleInterventions

The paper

Silvia Fisch, Eitan J. Neugut, Nicole Cornet, Daniel Freedberg

New York

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, late-breaking 2824-LB

doi.org/10.2337/db26-2824-lb

Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk